A Real‐World Experience of Desidustat in Maintenance Hemodialysis Patients—A 1‐Year Retrospective Database Analysis From a Single Center
Desidustat is effective and safe in management of anemia in hemodialysis patients over a period of 1 year. It helps in achieving target hemoglobin in majority of patients within 6 months.
Authors
- P Sanwaria
- Tarun Jeloka (ORCID: https://orcid.org/0000-0001-7775-7413)
- Saurabh Khiste
Institutions
- Manipal Hospital (IN)
Publication Details
- Journal
- Seminars in Dialysis
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/sdi.13249
- Citations
- 1
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.77